The Top Line

Advancements in cell & gene therapy manufacturing (Part II)

May 17, 2024
Delara Motlagh, Becky Butler Cap, and Kevin Kyle discuss cell collection, scaling projects from lab to clinic, and Germfree's decentralized manufacturing mission. Topics include locking in process decisions early, Catalent's new production site, and Germfree's recent asset acquisition from Orgenesis.
Ask episode
Chapters
Transcript
Episode notes